[Traumatic brain injury in anticoagulated patients : Hemostatic therapy for the treatment of intracranial hemorrhage]. / Schädel-Hirn-Trauma unter antithrombotischer Medikation : Hämostaseologische Therapie bei intrakraniellen Blutungen.
Unfallchirurg
; 120(3): 220-228, 2017 Mar.
Article
en De
| MEDLINE
| ID: mdl-26684296
Impaired hemostasis represents a major risk factor for increased morbidity and mortality in patients with traumatic intracranial hemorrhage. In cases of polytrauma with major bleeding, hyperfibrinolysis may develop and this may result in excessive coagulopathy. Patients receiving antithrombotic medication and suffering from intracranial hemorrhage are at particular risk for the development of neurological sequelae due to the increased tendency to bleeding. This article outlines the principles of hemostatic therapy of traumatic intracranial hemorrhage during antithrombotic treatment. The basic principles of the pathophysiology and effects of coagulation impairment in this patient population are reviewed. Furthermore, the use of specific coagulation tests and the administration of hemostatic substances are discussed.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pruebas de Coagulación Sanguínea
/
Hemostáticos
/
Hemorragia Cerebral
/
Lesiones Traumáticas del Encéfalo
/
Anticoagulantes
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
De
Revista:
Unfallchirurg
Asunto de la revista:
TRAUMATOLOGIA
Año:
2017
Tipo del documento:
Article
Pais de publicación:
Alemania